SEC CIK 1780058
REINHARDT MAX
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PCRXview stock → | 29,225 | 2023-06-07 |
| OFIXview stock → | 25,348 | 2026-03-05 |
Position History — PCRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PCRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2023-06-07 | Open-market sale | 1,099 | $37.87 | 29,225 |
| 2023-06-06 | Open-market sale | 1,054 | $38.99 | 30,324 |
| 2022-10-07 | Open-market sale | 1,380 | $58.00 | 31,378 |
| 2022-06-08 | Grant / award (derivative) | 19,900 | $0.00 | 19,900 |
| 2022-06-08 | Grant / award | 7,950 | $0.00 | 32,250 |
| 2022-06-07 | Open-market sale | 2,433 | $62.00 | 24,400 |
| 2022-06-06 | Open-market sale | 2,817 | $61.37 | 26,833 |
| 2022-04-21 | Option exercise (derivative) | 12,500 | $0.00 | 100,000 |
| 2022-04-21 | Option exercise | 12,500 | $42.54 | 39,474 |
| 2022-04-21 | Open-market sale | 9,824 | $73.25 | 29,650 |
| 2022-04-20 | Option exercise (derivative) | 12,500 | $0.00 | 112,500 |
| 2022-04-20 | Open-market sale | 9,764 | $73.99 | 26,974 |
| 2022-04-20 | Option exercise | 12,500 | $42.54 | 36,738 |
| 2022-04-19 | Option exercise (derivative) | 12,500 | $0.00 | 125,000 |
| 2022-04-19 | Option exercise | 12,500 | $42.54 | 33,559 |
| 2022-04-19 | Open-market sale | 9,321 | $72.25 | 24,238 |
| 2022-04-18 | Option exercise (derivative) | 12,500 | $0.00 | 137,500 |
| 2022-04-18 | Option exercise | 12,500 | $42.54 | 30,000 |
| 2022-04-18 | Open-market sale | 8,941 | $73.55 | 21,059 |
| 2021-07-02 | Open-market sale | 421 | $59.76 | 17,500 |
| 2021-06-09 | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2021-06-09 | Grant / award | 7,000 | $0.00 | 17,500 |
| 2021-06-07 | Open-market sale | 2,278 | $60.50 | 10,500 |
| 2021-06-04 | Open-market sale | 1,222 | $61.04 | 12,778 |
| 2021-01-06 | Open-market sale | 110 | $60.81 | 14,000 |
| 2020-11-13 | Option exercise (derivative) | 25,000 | $0.00 | 150,000 |
| 2020-11-13 | Open-market sale | 4,000 | $62.67 | 35,000 |
| 2020-11-13 | Open-market sale | 21,000 | $63.51 | 14,000 |
| 2020-11-13 | Option exercise | 25,000 | $42.54 | 39,000 |
| 2020-09-17 | Option exercise (derivative) | 25,000 | $0.00 | 175,000 |
| 2020-09-17 | Open-market sale | 22,532 | $59.75 | 16,888 |
| 2020-09-17 | Open-market sale | 2,888 | $60.26 | 14,000 |
| 2020-09-17 | Option exercise | 25,000 | $42.54 | 39,000 |
| 2020-06-09 | Grant / award (derivative) | 35,000 | $0.00 | 35,000 |
| 2020-06-09 | Grant / award | 14,000 | $0.00 | 14,000 |
| 2019-07-02 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.